Under the theme of personalized medicine, in vitro diagnostics will play an increasingly important role in new drug entries and new therapies
Gerry McDougall, PriceWaterhouseCoopers
Advertisement
Articles by Gerry McDougall, PriceWaterhouseCoopers
Advertisement
Latest Updated Articles
- The Rise of 'Companion' Diagnostics for Specialty Pharmaceuticals
Published: October 11th 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
It’s Official: CMS Unveils Big Price Cuts for 15 High-Cost Medicare Drugs in Latest IRA Negotiation Round
2
The New Realities of DSCSA Compliance
3
AstraZeneca Invests $2 Billion to Expand Biologics Manufacturing Footprint in Maryland
4
Medicare Set to Unveil Prices for 15 High-Cost Drugs
5
